On Monday, Biolife Solutions Inc (NASDAQ: BLFS) opened higher 5.08% from the last session, before settling in for the closing price of $20.88. Price fluctuations for BLFS have ranged from $14.84 to $29.55 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 42.91%. Company’s average yearly earnings per share was noted 52.57% at the time writing. With a float of $45.10 million, this company’s outstanding shares have now reached $46.91 million.
Considering the fact that the conglomerate employs 159 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 64.93%, operating margin of -14.75%, and the pretax margin is -19.98%.
Biolife Solutions Inc (BLFS) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Biolife Solutions Inc is 4.05%, while institutional ownership is 100.98%. The most recent insider transaction that took place on Apr 01 ’25, was worth 130,771. In this transaction Chief Human Resources Officer of this company sold 5,771 shares at a rate of $22.66, taking the stock ownership to the 80,094 shares. Before that another transaction happened on Apr 01 ’25, when Company’s Chief Marketing Officer sold 8,902 for $22.66, making the entire transaction worth $201,719. This insider now owns 135,956 shares in total.
Biolife Solutions Inc (BLFS) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 52.57% per share during the next fiscal year.
Biolife Solutions Inc (NASDAQ: BLFS) Trading Performance Indicators
Check out the current performance indicators for Biolife Solutions Inc (BLFS). In the past quarter, the stock posted a quick ratio of 3.66. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.10. Likewise, its price to free cash flow for the trailing twelve months is 198.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.26, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach 0.12 in one year’s time.
Technical Analysis of Biolife Solutions Inc (BLFS)
Compared to the last year’s volume of 0.35 million, its volume of 0.82 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 21.48%. Additionally, its Average True Range was 1.77.
During the past 100 days, Biolife Solutions Inc’s (BLFS) raw stochastic average was set at 26.88%, which indicates a significant decrease from 38.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.05% in the past 14 days, which was higher than the 57.81% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $25.75, while its 200-day Moving Average is $24.72. Nevertheless, the first resistance level for the watch stands at $22.99 in the near term. At $24.04, the stock is likely to face the second major resistance level. The third major resistance level sits at $25.96. If the price goes on to break the first support level at $20.02, it is likely to go to the next support level at $18.10. Now, if the price goes above the second support level, the third support stands at $17.05.
Biolife Solutions Inc (NASDAQ: BLFS) Key Stats
There are currently 47,000K shares outstanding in the company with a market cap of 1.03 billion. Presently, the company’s annual sales total 82,250 K according to its annual income of -20,180 K. Last quarter, the company’s sales amounted to 30,570 K and its income totaled -1,700 K.
